Increased Pancreatic β-Cell Proliferation Mediated by CREB Binding Protein Gene Activation

REFERENCES

• Abraham, E. J., C. A. Leech, J. C. Lin, H. Zulewski, and J. F. Habener. 2002. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 143:3152–3161.
   PubMed Web of Science ®Google Scholar
• Bonner-Weir, S. 2001. Beta-cell turnover: its assessment and implications. Diabetes 50(Suppl. 1):S20–S24.
   PubMedGoogle Scholar
• Bonner-Weir, S. 2000. Islet growth and development in the adult. J. Mol. Endocrinol. 24:297–302.
   PubMed Web of Science ®Google Scholar
• Bromley, M., D. Rew, A. Becciolini, M. Balzi, C. Chadwick, D. Hewitt, Y. Q. Li, and C. S. Potten. 1996. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Eur. J. Histochem. 40:89–100.
   PubMed Web of Science ®Google Scholar
• Brubaker, P. L., and D. J. Drucker. 2004. Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145:2653–2659.
   PubMed Web of Science ®Google Scholar
• Dor, Y., J. Brown, O. I. Martinez, and D. A. Melton. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–46.
   PubMed Web of Science ®Google Scholar
• Drucker, D. J. 2003. Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145–5148.
   PubMed Web of Science ®Google Scholar
• Ema, M., K. Hirota, J. Mimura, H. Abe, J. Yodoi, K. Sogawa, L. Poellinger, and Y. Fujii-Kuriyama. 1999. Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18:1905–1914.
   PubMed Web of Science ®Google Scholar
• Fernandes, A., L. C. King, Y. Guz, R. Stein, C. V. Wright, and G. Teitelman. 1997. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology 138:1750–1762.
   PubMed Web of Science ®Google Scholar
• Flier, S. N., R. N. Kulkarni, and C. R. Kahn. 2001. Evidence for a circulating islet cell growth factor in insulin-resistant states. Proc. Natl. Acad. Sci. USA 98:7475–7480.
   PubMedGoogle Scholar
• Georgia, S., and A. Bhushan. 2004. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Investig. 114:963–968.
   PubMed Web of Science ®Google Scholar
• Gonzalez, G. A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675–680.
   PubMed Web of Science ®Google Scholar
• Goren, H. J., R. N. Kulkarni, and C. R. Kahn. 2004. Glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice: C57BL/6, C57BLKS/6, DBA/2, and 129X1. Endocrinology 145:3307–3323.
   PubMedGoogle Scholar
• Gunton, J. E., R. N. Kulkarni, S. Yim, T. Okada, W. J. Hawthorne, Y. H. Tseng, R. S. Roberson, C. Ricordi, P. J. O'Connell, F. J. Gonzalez, and C. R. Kahn. 2005. Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337–349.
   PubMed Web of Science ®Google Scholar
• Guz, Y., I. Nasir, and G. Teitelman. 2001. Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 142:4956–4968.
   PubMed Web of Science ®Google Scholar
• Hennige, A. M., D. J. Burks, U. Ozcan, R. N. Kulkarni, J. Ye, S. Park, M. Schubert, T. L. Fisher, M. A. Dow, R. Leshan, M. Zakaria, M. Mossa-Basha, and M. F. White. 2003. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J. Clin. Investig. 112:1521–1532.
   PubMed Web of Science ®Google Scholar
• Holz, G. G. 2004. Epac: a new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes 53:5–13.
   PubMed Web of Science ®Google Scholar
• Holz, G. G., IV, W. M. Kuhtreiber, and J. F. Habener. 1993. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362–365.
   PubMed Web of Science ®Google Scholar
• Hussain, M. A., P. B. Daniel, and J. F. Habener. 2000. Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells. Diabetes 49:1681–1690.
   PubMed Web of Science ®Google Scholar
• Hussain, M. A., C. P. Miller, and J. F. Habener. 2002. Brn-4 transcription factor expression targeted to the early developing mouse pancreas induces ectopic glucagon gene expression in insulin-producing beta cells. J. Biol. Chem. 277:16028–16032.
   PubMed Web of Science ®Google Scholar
• Ianus, A., G. G. Holz, N. D. Theise, and M. A. Hussain. 2003. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Investig. 111:843–850.
   PubMed Web of Science ®Google Scholar
• Inada, A., Y. Hamamoto, Y. Tsuura, J. Miyazaki, S. Toyokuni, Y. Ihara, K. Nagai, Y. Yamada, S. Bonner-Weir, and Y. Seino. 2004. Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells. Mol. Cell. Biol. 24:2831–2841.
   PubMedGoogle Scholar
• Jhala, U. S., G. Canettieri, R. A. Screaton, R. N. Kulkarni, S. Krajewski, J. Reed, J. Walker, X. Lin, M. White, and M. Montminy. 2003. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 17:1575–1580.
   PubMed Web of Science ®Google Scholar
• Kieffer, T. J., and J. F. Habener. 1999. The glucagon-like peptides. Endocr. Rev. 20:876–913.
   PubMed Web of Science ®Google Scholar
• Kulkarni, R. N., J. C. Bruning, J. N. Winnay, C. Postic, M. A. Magnuson, and C. R. Kahn. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339.
   PubMed Web of Science ®Google Scholar
• Kulkarni, R. N., U. S. Jhala, J. N. Winnay, S. Krajewski, M. Montminy, and C. R. Kahn. 2004. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J. Clin. Investig. 114:828–836.
   PubMed Web of Science ®Google Scholar
• Kwok, R. P., J. R. Lundblad, J. C. Chrivia, J. P. Richards, H. P. Bachinger, R. G. Brennan, S. G. Roberts, M. R. Green, and R. H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223–226.
   PubMed Web of Science ®Google Scholar
• Li, Y., T. Hansotia, B. Yusta, F. Ris, P. A. Halban, and D. J. Drucker. 2003. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J. Biol. Chem. 278:471–478.
   PubMed Web of Science ®Google Scholar
• Lipsett, M., and D. T. Finegood. 2002. Beta-cell neogenesis during prolonged hyperglycemia in rats. Diabetes 51:1834–1841.
   PubMed Web of Science ®Google Scholar
• List, J. F., and J. F. Habener. 2004. Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 286:E875–E881.
   PubMedGoogle Scholar
• Marzo, N., C. Mora, M. E. Fabregat, J. Martin, E. F. Usac, C. Franco, M. Barbacid, and R. Gomis. 2004. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia 47:686–694. (In German.)
   PubMed Web of Science ®Google Scholar
• Michael, M. D., R. N. Kulkarni, C. Postic, S. F. Previs, G. I. Shulman, M. A. Magnuson, and C. R. Kahn. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6:87–97.
   PubMed Web of Science ®Google Scholar
• Miyawaki, K., Y. Yamada, H. Yano, H. Niwa, N. Ban, Y. Ihara, A. Kubota, S. Fujimoto, M. Kajikawa, A. Kuroe, K. Tsuda, H. Hashimoto, T. Yamashita, T. Jomori, F. Tashiro, J. Miyazaki, and Y. Seino. 1999. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc. Natl. Acad. Sci. USA 96:14843–14847.
   PubMed Web of Science ®Google Scholar
• Montminy, M. 1997. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 66:807–822.
   PubMed Web of Science ®Google Scholar
• Piston, D., and G. Patterson. 2005. Linear relationship between glucokinase expression, metabolic redox state and insulin secretion, vol. 16. Karger, Basel, Switzerland.
   Google Scholar
• Puigserver, P., and B. M. Spiegelman. 2003. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24:78–90.
   PubMed Web of Science ®Google Scholar
• Rosen, E. D., R. N. Kulkarni, P. Sarraf, U. Ozcan, T. Okada, C. H. Hsu, D. Eisenman, M. A. Magnuson, F. J. Gonzalez, C. R. Kahn, and B. M. Spiegelman. 2003. Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol. Cell. Biol. 23:7222–7229.
   PubMed Web of Science ®Google Scholar
• Scrocchi, L. A., T. J. Brown, N. MacLusky, P. L. Brubaker, A. B. Auerbach, A. L. Joyner, and D. J. Drucker. 1996. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat. Med. 2:1254–1258.
   PubMed Web of Science ®Google Scholar
• Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827–4833.
   PubMed Web of Science ®Google Scholar
• Stoffers, D. A., T. J. Kieffer, M. A. Hussain, D. J. Drucker, S. Bonner-Weir, J. F. Habener, and J. M. Egan. 2000. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741–748.
   PubMed Web of Science ®Google Scholar
• Teitelman, G. 1996. Induction of beta-cell neogenesis by islet injury. Diabetes Metab. Rev. 12:91–102.
   PubMedGoogle Scholar
• Tuttle, R. L., N. S. Gill, W. Pugh, J. P. Lee, B. Koeberlein, E. E. Furth, K. S. Polonsky, A. Naji, and M. J. Birnbaum. 2001. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat. Med. 7:1133–1137.
   PubMed Web of Science ®Google Scholar
• Yoon, J. C., P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, C. B. Newgard, and B. M. Spiegelman. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131–138.
   PubMed Web of Science ®Google Scholar
• Zanger, K., L. E. Cohen, K. Hashimoto, S. Radovick, and F. E. Wondisford. 1999. A novel mechanism for cyclic adenosine 3′,5′-monophosphate regulation of gene expression by CREB-binding protein. Mol. Endocrinol. 13:268–275.
   PubMedGoogle Scholar
• Zhou, X. Y., N. Shibusawa, K. Naik, D. Porras, K. Temple, H. Ou, K. Kaihara, M. W. Roe, M. J. Brady, and F. E. Wondisford. 2004. Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nat. Med. 10:633–637.
   PubMed Web of Science ®Google Scholar
• Zulewski, H., E. J. Abraham, M. J. Gerlach, P. B. Daniel, W. Moritz, B. Muller, M. Vallejo, M. K. Thomas, and J. F. Habener. 2001. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50:521–533.
   PubMed Web of Science ®Google Scholar